IGF2 and cholangiocarcinoma: In cholangiocarcinoma (CCA), the interaction between cancer cells and CAFs mediated by insulin-like growth factor 2 (IGF2), insulin receptor (IR) and IGF1 receptor (IGF1R) was found to regulate ERL resistance.